PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience

In recent years, the preferentially expressed antigen in melanoma (PRAME) has also been used in the histopathological diagnosis of melanocytic lesions, in order to understand if it could constitute a valid, inexpensive, and useful resource in dermatopathological fields. We performed a double-center...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzato, Gerardo, Cascardi, Eliano, Colagrande, Anna, Belsito, Vincenzo, Lospalluti, Lucia, Foti, Caterina, Arezzo, Francesca, Dellino, Miriam, Casatta, Nadia, Lupo, Carmelo, Buongiorno, Luigi, Stellacci, Alessandra, Marrone, Maricla, Ingravallo, Giuseppe, Maiorano, Eugenio, Resta, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498170/
https://www.ncbi.nlm.nih.gov/pubmed/36140597
http://dx.doi.org/10.3390/diagnostics12092197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498170/
https://www.ncbi.nlm.nih.gov/pubmed/36140597
http://dx.doi.org/10.3390/diagnostics12092197

Ejemplares similares